OncologyDr. Preeti VijayakumaranEsophageal Cancer Diagnosis & Treatment

Consultant, Surgical Oncology, Artemis Hospitals, Gurugram

Part 9 of 10 in Diagnosis and Management of Esophageal Cancer

Screening, Prevention and Risk Factors for Esophageal Cancer

September 6, 2026

Prevention and screening for esophageal cancer both start from the same point: understanding that adenocarcinoma and squamous cell carcinoma are driven by genuinely different risk factors, even though they end up looking similar by the time a patient presents.

Two Subtypes, Two Sets of Risk Factors

For adenocarcinoma, the main drivers are obesity, chronic reflux disease, and smoking and alcohol use, so limiting smoking and alcohol, and medically managing an existing gastroesophageal reflux disease rather than leaving it untreated, genuinely reduces risk. For squamous cell carcinoma, the pathology relates more to smoking and to diet habits, and regulating both can make a real difference. Notably, there is no established genetic risk factor that explains why the disease is significantly more common in men than in women, despite this being a consistent finding worldwide; the working explanation leans on these behavioural and dietary risk factors rather than genetics.

When to Start Screening

In practice, screening by endoscopy is recommended starting at age 35 to 40, particularly for patients with reflux symptoms or a risk of Barrett's esophagus, though the exact age varies by institutional protocol and guideline. Patients who already have an existing predisposing condition should be started on more stringent endoscopic surveillance earlier rather than later.

What Endoscopic Mapping and Surveillance Look Like

For patients under surveillance, any area on endoscopic mapping that shows dysplastic change is biopsied. If repeated biopsies show no dysplasia, the patient stays on routine surveillance. Low-grade dysplasia is followed up rather than treated immediately. High-grade dysplasia in a flat lesion under 2 cm is ablated, while high-grade dysplasia over 2 cm, or with a nodular appearance, is taken for endoscopic resection with histopathology follow-up on the specimen.

Caustic Injury: An Under-Recognised Precancerous Pathway

One risk pathway that doesn't fit neatly into either subtype's usual list is caustic esophageal injury, seen in practice from cases of chemical poisoning in suicide attempts. This injury can cause chronic esophagitis, which over time can progress to stricturous disease and become a genuine predisposing cause of esophageal cancer. Any patient who survives such an injury and goes on to develop stricturous disease should be placed on a very stringent surveillance protocol going forward, precisely because that chronic esophagitis functions as a real precancerous condition rather than a benign, self-limiting injury. Preventively, patients who develop extensive stricturous disease with significant dysphagia and an inability to sustain oral nutrition are offered an esophagectomy with a neo-esophagus, while those who do not develop stricture are managed with six-monthly endoscopic evaluation and biopsy of any suspicious area instead, with further imaging reserved for a biopsy-proven finding.

This article is based on a Jivo Masterclass session conducted by Dr. Preeti Vijayakumaran, Consultant, Surgical Oncology, Artemis Hospital, Gurugram. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

This guide is based on a live Jivo Masterclass: Dr. Preeti Vijayakumaran taught doctors across Africa on March 16, 2025.

FROM THE LIVE Q&A

DR

Dr. Wassim

In routine practice we frequently encounter cases of PPD poisoning due to suicide attempts, which lead to caustic esophageal injury resulting in chronic esophagitis. In such cases, can chronic esophagitis be considered a precancerous lesion?

PV

Dr. Preeti Vijayakumaran

That is a very valid question. Even in our community we see a lot of cases of caustic esophageal injury, and this chronic esophagitis can eventually lead to stricturous disease and become a predisposing cause for esophageal cancer. Patients who survive such an injury and go on to develop stricturous disease should be kept on a very stringent surveillance protocol.

See all 11 questions from this masterclass →

Book a Consultation with Dr. Preeti Vijayakumaran

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

Is there any specific age at which to start screening by endoscopy or another modality?

In our practice, screening is recommended after the age of 35 to 40 years, particularly for patients with reflux symptoms or a risk of Barrett's esophagus, though this is a variable number depending on institutional protocol. In practice, we take these patients up for endoscopic mapping: any area showing dysplastic change is biopsied. If there is no evidence of dysplasia after multiple biopsies, the patient is kept on surveillance. Low-grade dysplasia is followed up. High-grade dysplasia in a flat lesion under 2 cm is ablated, and high-grade dysplasia over 2 cm, or with a nodular appearance, is taken for endoscopic resection with histopathology follow-up on the specimen.

In this case of caustic injury from PPD poisoning, what preventive measures should be taken?

Most of these patients go on to develop stricturous disease, leading to significant dysphagia and a chronic inability to take oral nutrition. In such patients, an esophagectomy with a neo-esophagus is offered. In patients who do not develop stricturous disease, six-monthly endoscopic evaluation with biopsy of any suspicious area is done instead, and further imaging is not required unless a biopsy proves malignancy.

How do you differentiate gastroesophageal junction cancer and lower esophageal cancer, and the difference in their care?

The protocol is endoscopic mapping. The endoscopist localises exactly where the tumour sits relative to the GE junction, using a standard landmark of around 40 cm from the incisors, which varies slightly with the patient's own oesophageal length. Once that is determined, the malignancy is mapped against the gastroesophageal junction, and this is cross-checked against the axial imaging. If there is any disagreement between the endoscopic and imaging findings, the axial imaging representation is preferred to finalise the diagnosis.

What is the role of immunotherapy in esophageal cancer?

Immunotherapy's role is currently established in the adjuvant setting, more so for esophageal squamous cell carcinoma. A patient who completes neoadjuvant therapy, undergoes surgery, and is found to have residual disease is followed with adjuvant nivolumab. If there is no residual disease, adjuvant nivolumab is not advocated. In the neoadjuvant setting, the role of immunotherapy is still experimental and yet to be answered.

Cryotherapy is one of the treatment options for the cancer. Would you repeat the disadvantages of applying cryotherapy for esophageal cancer?

Cryotherapy, along with other ablative therapies, is applicable only in very early and especially screen-detected cases of esophageal malignancy. Staging accuracy is critical here: if endoscopy and endoscopic ultrasound confirm a flat, high-grade dysplastic lesion or an early intramucosal carcinoma, ablation can be applied, though it does leave structural changes at the site that make future surveillance harder. If there is any suspicion of nodular disease, or of invasion into the submucosa or muscularis propria, endoscopic resection is recommended over an ablative procedure like cryotherapy alone.

What are the main risk factors for esophageal adenocarcinoma?

Obesity, chronic reflux disease, and smoking and alcohol use.

What are the main risk factors for esophageal squamous cell carcinoma?

Smoking and diet habits are the main drivers.

At what age should esophageal cancer screening start?

Around 35 to 40 years, particularly for patients with reflux symptoms or Barrett's esophagus risk, though this varies by institutional protocol.

Can caustic esophageal injury lead to cancer?

Yes. Chronic esophagitis following caustic injury can progress to stricturous disease and become a predisposing cause of esophageal cancer, which is why survivors need stringent ongoing surveillance.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion